We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Surgery of the Colon Management and Complications

Oliver H. Beahrs, MD; James G. Hoehn, MD; William H. Dearing, MD
Arch Surg. 1969;98(4):480-486. doi:10.1001/archsurg.1969.01340100112015.
Text Size: A A A
Published online


Three to four decades ago the mortality associated with colon and rectal surgery was 20% or greater and the morbidity was high. This experience earlier had led to the development of multiple-staged operations for the management of neoplastic and inflammatory diseases of the large bowel and rectum. With the introduction of chemotherapeutic agents (the sulfonamides, which were poorly absorbed in the gastrointestinal tract)1 in the late 1930's, the mortality for colon surgery promptly began to fall; and over the next decade it was reduced to approximately 5% in most reports. Shortly after the sulfonamides, antibiotics came into use and aided further the management of patients having colon surgery. Poth2,3 advocated the combined use of phthalylsulfathiazole (Sulfathalidine) and neomycin as the best prophylactic drugs for suppressing the widest number and variety of intestinal microorganisms. This combination of drugs or some modification of it has been used and recommended by


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.